Clinical evaluation of HuDo-CSPG4 DNA electroporation as adjuvant treatment for canine oral malignant melanoma: comparison of two vaccination protocols.

those achieving an anti-CSPG4 fold change >1.1 after the 6 th vaccination ( Figure 7A ) or at any subsequent time points during treatment ( Figure 7B ), showed a positive trend toward prolonged overall survival compared to non-responders.

also in 11,005 other papers